29588-08-7 Usage
Description
(S)-5-[(4-hydroxyphenyl)methyl]-3-phenyl-2-thioxoimidazolidin-4-one is a complex chemical compound characterized by its unique molecular structure. It features a five-membered imidazolidin-4-one ring with a thioxo group and a phenyl group attached at distinct positions. The presence of a (4-hydroxyphenyl)methyl group further contributes to its structural complexity. (S)-5-[(4-hydroxyphenyl)methyl]-3-phenyl-2-thioxoimidazolidin-4-one holds potential for pharmaceutical applications, although further research is necessary to ascertain its specific uses and properties.
Uses
Used in Pharmaceutical Industry:
(S)-5-[(4-hydroxyphenyl)methyl]-3-phenyl-2-thioxoimidazolidin-4-one is used as a potential pharmaceutical agent for [application reason] due to its complex molecular structure and the presence of various functional groups.
Used in Research and Development:
In the field of chemical research and development, (S)-5-[(4-hydroxyphenyl)methyl]-3-phenyl-2-thioxoimidazolidin-4-one serves as a subject for further investigation to explore its potential applications, properties, and interactions with biological systems.
Please note that the specific application reasons and industries for (S)-5-[(4-hydroxyphenyl)methyl]-3-phenyl-2-thioxoimidazolidin-4-one are not provided in the given materials. The uses mentioned above are general assumptions based on the compound's potential pharmaceutical relevance and its complex structure, which may be of interest in research and development. Further information would be required to provide more detailed and accurate applications.
Check Digit Verification of cas no
The CAS Registry Mumber 29588-08-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,5,8 and 8 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 29588-08:
(7*2)+(6*9)+(5*5)+(4*8)+(3*8)+(2*0)+(1*8)=157
157 % 10 = 7
So 29588-08-7 is a valid CAS Registry Number.
InChI:InChI=1/C16H14N2O2S/c19-13-8-6-11(7-9-13)10-14-15(20)18(16(21)17-14)12-4-2-1-3-5-12/h1-9,14,19H,10H2,(H,17,21)
29588-08-7Relevant articles and documents
Modulation of the pharmacological activities of secretory phospholipase A2 from Crotalus durissus cascavella induced by naringin
Santos, Marcelo L.,Toyama, Daniela O.,Oliveira, Simone C. B.,Cotrim, Camila A.,Diz-Filho, Eduardo B. S.,Fagundes, Fabio H. R.,Soares, Veronica C. G.,Aparicio, Ricardo,Toyama, Marcos H.
experimental part, p. 738 - 761 (2011/04/15)
In this work we have characterized the action of the naringin, a flavonoid found in grapefruit and known for its various pharmacological effects, which include antioxidant, blood lipid lowering and anticancer activity, on the structure and biochemical activities of a secretory phospholipase A (sPLA2) from Crotalus durissus cascavella, an important protein involved in the releasinge of arachidonic acid in phospholipid membranes. sPLA2 was incubated with naringin (mol:mol) at 37 °C and a discrete reduction in the UV scanning signal and a modification of the circular dichroism spectra were observed after treatment with naringin, suggesting modifications of the secondary structure of the protein. This flavonoid was able to decrease enzymatic activity and some pharmacological effects, such as myonecrosis, platelet aggregation, and neurotoxic activity caused by sPLA2, however, the inflammatory effect was not affected by naringin. In addition, small angle X-ray scattering (SAXS) data were collected for sPLA2 and naringin-treated sPLA2 to evaluate possible modifications of the protein structure. These structural investigations have shown that sPLA2 is an elongated dimer in solution and after treatment with naringin a conformational change in the dimeric configuration was observed. Our results suggest that structural modification may be correlated with the loss of enzymatic activity and alterations in pharmacological properties.
